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The birth of NeuroImage: ClinicalOne of the great potentials of human brain imaging is to under-
stand the links between pathophysiology of disease and disturbances
in cognitive and behavioural function. Since the emergence of neuro-
imaging as a ﬁeld in the 1970s the number of scanners and methods
for analysing circuits, systems and networks has grown exponential-
ly. We are now beneﬁtting from an unparalleled sophistication in
mathematical methods and computational tools for interrogating
these rich data. The journal NeuroImage has provided an invaluable
environment for vetting and promoting promising new methods
and has been a home for many discoveries into normal brain function.
Unfortunately, opportunities to publish clinical research involving
state of the art imaging and analysis methods have been more limited.
Many clinical neurology and psychiatry journals are constrained by
editorial expertise that is capable of handling brain imaging involving
only the simplest of analysis methods. As the brain imaging ﬁeld relies
more heavily on multivariate techniques, graphical analysis, morpho-
metrics, machine learning algorithms and dynamic modelling, those
journals with a more purely clinical expertise will struggle to keep
abreast with the computational and conceptual changes taking place.
The editorial decision to limit clinical research atNeuroImage emerged
from discussions of the editors in 2003. It was noted that, amid the
growing numbers of papers submitted to the journal, a sizeable, and
growing, proportion were “clinical”, using data from patients or seeking
to answer questions related to speciﬁc diseases. It transpired that some
of the editors had been rejecting such papers, feeling that theywere inap-
propriate for a journal whose core strength lay in the development of
methods and imaging neuroscience relating to the structure, function
and development of the healthy brain. A consensus was reached to wel-
come the submission of clinical papers with the caveat that they should
have clear implications for normal brain structure and/or function, rather
as neuropsychology uses the careful study of lesions to gain insights to
healthy psychological processes. Work that simply described the impact
of disease or lesions using imaging measures, without trying to delve
more deeply into the meaning of such altered patterns, was rejected.
This distinction could be subtle, and there was real concern that the
journal's policy could be perceived as inconsistent. Over subsequent
years, the volume of work submitted to NeuroImage grew steadily and,
as predicted, a substantial proportion of this workwas clinically oriented,
and subject to triage due to it falling outside of scope. Fortunately, all of
the editors recognised that clinical imaging neuroscience was a quickly
growing ﬁeld and that, given our collective desire to reﬂect and nurture
the development of the ﬁeld in all its forms, simply ignoring a large
part of clinical imaging would prevent us from publishing some of the
most elegant science in the ﬁeld. In addition, the appearance of remark-
able new methods in image analysis ampliﬁed the potential value of2213-1582 © 2012 The Authors. Published by Elsevier Inc.
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and testing of pathophysiological models.
Recognising the need to foster the emerging ﬁeld of clinical neuro-
imaging, discussions about the possibility of a clinical sister journal
gathered pace from 2010 until, in May 2012, NeuroImage: Clinical
was ofﬁcially opened for business: an electronic, open access journal
aiming to publish high-quality, clinically-oriented imaging neuroscience
and employing an editorial board covering all of the key areas of this
large and exciting ﬁeld.
As editors, one of our aspirations for NeuroImage: Clinical is that it
beneﬁts from the sophistication in design, analysis and interpretation
that fundamental research in human brain imaging has generated
over the past three decades. Brain imaging in healthy populations
has reached a maturity that brings with it an increasing demand for
studies that move beyond “mapping” of structure–function relation-
ships in the human brain, an enterprise that, at its crudest has been
accused of descending into “blobology”. The ﬁeld as a whole is in-
creasingly acknowledging the fact that an activation study that is
not under-pinned by careful hypothesis-testing will inevitably pro-
duce conclusions that are post hoc and speculative, based upon
poorly-framed “reverse inference” and unlikely to offer real insights
into how the brain carries out its functions or indeed how those
functions are organised. The seductive powers of the brain image
are increasingly recognised as potentially meretricious and one
can detect growing suspicion in the popular media where neuroim-
aging studies have, for some time, been excitedly, and all too often,
uncritically reported and extrapolated well beyond their limits. This
critical scrutiny is to be welcomed: it signiﬁes a more realistic view
of the possibilities afforded by these exciting techniques and it
brings us back to the bread and butter of science: using sensitive
measures to test hypotheses to which those measures are most
suited.
We believe that the same rigour must be applied in the clinical
brain-imaging ﬁeld, where the interpretive challenges are multiplied
as comparisons are made across different populations. Simple group-
wise differences, expressed in terms of an anomaly of structure or
function, offer little explanatory value and it is hard to see how they
advance our understanding of illness. At NeuroImage: Clinical, we
seek hypothesis-based studies in which imaging measures are used
in clever and creative, but realistic, ways in order to throw light on
clinical neurological and psychiatric problems. We see the role of
the journal as a cornerstone to support and nurture this scientiﬁc
area, offering a platform to optimise the impact of emergent ﬁndings
and to offer, too, the opportunity for scientists to shape and direct
critical areas through the publication of review and perspectiveicense.
ii Editorialarticles. As a sister journal to NeuroImage, we are in a unique position
of being able to draw on the talents of a remarkable pool of expert re-
viewers and editors who have made NeuroImage the home to some of
the most sophisticated and inspiring brain imaging research known.
This support allows us to make NeuroImage: Clinical a safe haven for
clinical imaging research involving “bleeding edge” methods that
push the boundaries of discovery.Scott Grafton
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